ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,069Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 1000

$656K Total Retail Price of All Prescriptions

Rank: 164 out of 1000

406 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

32% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 10,464 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 702 419 S3 1 1
SIMVASTATIN 622 477 2 3
PRAVASTATIN SODIUM 491 347 3 12
METFORMIN HCL 491 274 3 8
AMLODIPINE BESYLATE 488 351 5 6
TRAZODONE HCL 452 263 6 29
OMEPRAZOLE 420 264 7 2
LEVOTHYROXINE SODIUM 387 274 8 4
LISINOPRIL 347 261 9 5
GABAPENTIN 292 148 10 11
MELOXICAM 277 136 11 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 273 193 12 20
CLONIDINE HCL 269 152 13 27
CARVEDILOL 249 174 14 15
METHOCARBAMOL 240 148 R 15 79
CITALOPRAM HBR 231 172 16 17
TIZANIDINE HCL 205 118 17 76
FINASTERIDE 204 187 18 177
BUPROPION HCL SR 193 125 19 183
TAMSULOSIN HCL 186 167 20 33
ATENOLOL 181 128 21 24
GLIMEPIRIDE 181 114 21 34
WARFARIN SODIUM 177 146 23 22
SERTRALINE HCL 170 102 24 26
FENOFIBRATE 170 118 24 55
NEXIUM 159 79 26 23
FUROSEMIDE 157 102 27 7
DOXAZOSIN MESYLATE 151 137 28 111
CRESTOR 145 81 29 30
TRIAMTERENE-HCTZ 143 109 30 48
FLUTICASONE PROPIONATE 138 70 31 40
METOPROLOL TARTRATE 130 106 32 19
ALLOPURINOL 125 117 33 31
LOSARTAN-HYDROCHLOROTHIAZIDE 124 98 34 38
TRAMADOL HCL 122 76 35 13
BACLOFEN 119 67 36 129
HYDRALAZINE HCL 116 102 37 74
POTASSIUM CHLORIDE 106 76 38 10
FLUCONAZOLE 105 56 39 102
QUETIAPINE FUMARATE 103 18 40 75
ZOLPIDEM TARTRATE 103 57 40 16
METOPROLOL SUCCINATE 102 76 42 21
MIRTAZAPINE 99 64 43 56
PANTOPRAZOLE SODIUM 99 57 43 28
KLOR-CON M20 98 55 45 66
DONEPEZIL HCL 98 89 45 32
PROAIR HFA 98 42 45 50
RANITIDINE HCL 95 76 48 37
LOSARTAN POTASSIUM 95 54 48 25
LOVASTATIN 89 77 50 41
TORSEMIDE 88 57 51 137
BUSPIRONE HCL 87 70 52 110
HYDROCHLOROTHIAZIDE 87 48 52 9
SUBOXONE 85 11 54 163
CLOPIDOGREL 82 50 55 35
DICLOFENAC SODIUM 81 52 56 123
DOXYCYCLINE HYCLATE 78 52 57 97
ACTOS 77 48 58 119
CYMBALTA 76 49 59 53
FLUOXETINE HCL 74 35 60 51
ENALAPRIL MALEATE 73 47 61 58
PROMETHAZINE HCL 72 31 R 62 54
SUCRALFATE 72 52 62 144
LYRICA 72 0 62 47
ATORVASTATIN CALCIUM 69 57 65 18
SPIRIVA 68 41 66 64
MEGESTROL ACETATE 65 43 R 67 134
DILTIAZEM 24HR ER 63 55 68 189
ESCITALOPRAM OXALATE 61 16 69 60
ALENDRONATE SODIUM 60 40 70 57
MECLIZINE HCL 60 38 70 80
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 38 70 70
VERAPAMIL ER 59 42 73 86
DIGOXIN 59 54 73 52
DILTIAZEM ER 54 44 75 146
ADVAIR DISKUS 54 31 75 65
ACETAMINOPHEN-CODEINE 53 38 S3 77 127
NAPROXEN 51 35 78 81
PRIMIDONE 50 43 79 228
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.